-
@ 41d1479a:9db71bc7
2025-05-06 14:43:42
nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aesst3mr8r
✍️ Vertex Pharmaceuticals' stock plummeted 12% after the company reported disappointing first-quarter earnings, citing slow uptake for new drugs and a paused messenger RNA study.
👉 Vertex Pharmaceuticals' stock plummeted 12% after reporting disappointing first-quarter earnings
👉 Sales missed expectations, and adjusted earnings fell 15%
👉 New non-opioid pain treatment, Journavx, had insignificant sales
👉 Cystic fibrosis drug, Alyftrek, had light revenue
👉 Company reported a $100 million headwind from Russia due to an unauthorized copy of Trikafta
#DavidRisinger #BrianAbrahams #MylesMinter #ManiForoohar #AllisonGatlin #Russia #business
nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq5vjhrc964l25py2mlqpwuykcgh593d79axn2f926ngrq6j6h4vesju99vc